Oricell Therapeutics

Series-B+
oricell.com Biotech & Healthcare Shanghai, China 51-100
Total Funding $235M
Latest Round Undisclosed Series-B+
Last Announced Apr 10, 2026
Investors 17 Backers
Decision Makers 4 Verified

About Oricell Therapeutics

OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Shanghai, China
Team Size 51-100
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website oricell.com
Domain Registered Date Aug 21, 2019

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

5 Events
  1. Capital Raise

    Venture Round announced

    fundraisingfox.com

  2. Capital Raise

    Raised $70,000,000 · Series-B+

    startupintros.com

  3. Capital Raise

    Raised $45,000,000 · Series-B+

    startupintros.com

  4. Capital Raise

    Raised $120,000,000 · Series-B+

    startupintros.com

  5. Milestone

    Website domain registered

    oricell.com

Investors & Backers

17
Beijing E-town International Investment & Development
Beijing Medical and Health Industry Investment Fund
Boquan Equity Investment Management
C&D Emerging Investment
Elikon Venture
Frees Fund
J One Capital
Lichen Capital
Lucion
NGS Super
Qatari sovereign wealth fund
Qiming Venture Partners
Quan Capital
Shanghai Sci-Tech Innovation Center Capital
Suzhou Fund
Talon Capital
Vivo Capital

Funding History

4 Rounds
Venture Round · Apr 10, 2026
Series-B+ · Jan 13, 2026
Series-B+ · Feb 1, 2023
Series-B+ · Jul 1, 2022
$120,000,000 startupintros.com

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts